Evaluation of Skeletal Muscle Function Using Ultrasonic Elastography

April 6, 2023 updated by: Gang Hou, China-Japan Friendship Hospital

Evaluation of Skeletal Muscle Function in Patients With Chronic Obstructive Pulmonary Disease Before and After Lung Rehabilitation Training Using Ultrasonic Elastography

The goal of observational study is to evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:Evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography.

Participants will undergo pulmonary rehabilitation.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Chronic obstructive pulmonary disease

Description

Inclusion Criteria:

  • The age is between 40-80 years old
  • Patients with chronic obstructive pulmonary disease who meet the diagnostic criteria of GOLD guideline(2019)
  • There was no acute exacerbation in the past 12 weeks

Exclusion Criteria:

  • Hypoxemia (oxygen partial pressure is less than 60mmHg or oxygen saturation is less than 88% at rest), or patients who need continuous oxygen inhalation, or patients with any contraindication to exercise test (refer to the American Thoracic Association/American Association of Thoracic Physicians exercise test guidelines)
  • Oral glucocorticoids
  • Receive long-term oxygen therapy prescription
  • Have participated in supervised exercise programs in the past 12 months
  • History of other lung diseases, including pneumoconiosis, bronchiectasis, tuberculosis, primary pulmonary hypertension, pulmonary embolism, interstitial lung disease
  • Diseases that restrict the active exercise ability of participants or involve skeletal, neuromuscular, cardiovascular or metabolic disorders of muscle activity, such as tumors, diabetes, muscle weakness, etc

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
pulmonary rehabilitation
The participants would undergo pulmonary rehabilitation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness of pulmonary rehabilitation training
Time Frame: baseline
6-minute walking distance (6MWD)
baseline
Effectiveness of pulmonary rehabilitation training
Time Frame: 1 week after pulmonary rehabilitation
6-minute walking distance (6MWD)
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
Time Frame: baseline
COPD Assessment Test (CAT) score
baseline
Effectiveness of pulmonary rehabilitation training
Time Frame: 1 week after pulmonary rehabilitation
COPD Assessment Test (CAT) score
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
Time Frame: baseline
St. George's Respiratory Questionnaire (SGRQ)
baseline
Effectiveness of pulmonary rehabilitation training
Time Frame: 1 week after pulmonary rehabilitation
St. George's Respiratory Questionnaire (SGRQ)
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
Time Frame: baseline
modified Medical Research Council (mMRC) dyspnea scores
baseline
Effectiveness of pulmonary rehabilitation training
Time Frame: 1 week after pulmonary rehabilitation
modified Medical Research Council (mMRC) dyspnea scores
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
Time Frame: baseline
rectus femoris muscle strength via a dynamometer
baseline
Effectiveness of pulmonary rehabilitation training
Time Frame: 1 week after pulmonary rehabilitation
rectus femoris muscle strength via a dynamometer
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
Time Frame: baseline
6-30-second sit-to-stand test
baseline
Effectiveness of pulmonary rehabilitation training
Time Frame: 1 week after pulmonary rehabilitation
6-30-second sit-to-stand test
1 week after pulmonary rehabilitation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forced Expiratory Volume in 1-second(FEV1)
Time Frame: before pulmonary rehabilitation
Pulmonary function test
before pulmonary rehabilitation
Forced Expiratory Volume in 1-second(FEV1)
Time Frame: 1 week after pulmonary rehabilitation
Pulmonary function test
1 week after pulmonary rehabilitation
Ultrasonic elastic imaging of rectus femoris
Time Frame: before pulmonary rehabilitation
Ultrasonic elastography of skeletal muscle
before pulmonary rehabilitation
Ultrasonic elastic imaging of rectus femoris
Time Frame: 1 week after pulmonary rehabilitation
Ultrasonic elastography of skeletal muscle
1 week after pulmonary rehabilitation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 7, 2023

Primary Completion (Anticipated)

October 31, 2024

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

March 9, 2023

First Submitted That Met QC Criteria

April 6, 2023

First Posted (Actual)

April 10, 2023

Study Record Updates

Last Update Posted (Actual)

April 10, 2023

Last Update Submitted That Met QC Criteria

April 6, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-NHLHCRF-LX-01-0202-4

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on pulmonary rehabilitation

3
Subscribe